Makrilaki et al. assessed 19 patients with RA receiving treatment with tocilizumab for six months and identified a correlation between baseline chemerin levels and the health-assessment questionnaire disability index (HAQ-Di) score at baseline and at six months of tocilizumab treatment13. Here, RARRES2 is linked to rheumatoid arthritis.